Deciphering primary acinic cell carcinoma of the Breast: Insights from a comprehensive case series and Systematic review

IF 9.6 1区 医学 Q1 ONCOLOGY Cancer treatment reviews Pub Date : 2024-09-24 DOI:10.1016/j.ctrv.2024.102830
Ye Lu , Xiangyi Kong , Xiangyu Wang , Wenxiang Zhang , Yifei Li , Hao Dong , Zhongzhao Wang , Jidong Gao , Jing Wang
{"title":"Deciphering primary acinic cell carcinoma of the Breast: Insights from a comprehensive case series and Systematic review","authors":"Ye Lu ,&nbsp;Xiangyi Kong ,&nbsp;Xiangyu Wang ,&nbsp;Wenxiang Zhang ,&nbsp;Yifei Li ,&nbsp;Hao Dong ,&nbsp;Zhongzhao Wang ,&nbsp;Jidong Gao ,&nbsp;Jing Wang","doi":"10.1016/j.ctrv.2024.102830","DOIUrl":null,"url":null,"abstract":"<div><div>Primary acinic cell carcinoma (PACC) of the breast is a rare oncological entity that mimics acinar cell differentiation similar to that observed in salivary glands. This distinct subtype is characterized by low-grade malignancy and has only been documented in a limited number of cases. Despite its classification frequently as TNBC, PACC of the breast typically shows a comparatively favorable prognosis. Our study aims to enrich the current understanding of PACC through a comprehensive review of cases managed at our institution, analyzing their clinical, histopathological, and therapeutic profiles including chemotherapy and radiation therapy, and patient outcomes and allows us to compile a comprehensive dataset for in-depth analysis of treatment responses and long-term survival rates, contributing to a broader understanding of the disease’s natural history.</div></div>","PeriodicalId":9537,"journal":{"name":"Cancer treatment reviews","volume":"131 ","pages":"Article 102830"},"PeriodicalIF":9.6000,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment reviews","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0305737224001580","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Primary acinic cell carcinoma (PACC) of the breast is a rare oncological entity that mimics acinar cell differentiation similar to that observed in salivary glands. This distinct subtype is characterized by low-grade malignancy and has only been documented in a limited number of cases. Despite its classification frequently as TNBC, PACC of the breast typically shows a comparatively favorable prognosis. Our study aims to enrich the current understanding of PACC through a comprehensive review of cases managed at our institution, analyzing their clinical, histopathological, and therapeutic profiles including chemotherapy and radiation therapy, and patient outcomes and allows us to compile a comprehensive dataset for in-depth analysis of treatment responses and long-term survival rates, contributing to a broader understanding of the disease’s natural history.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
解密乳腺原发性尖细胞癌:综合病例系列和系统综述的启示
乳腺原发性尖细胞癌(PACC)是一种罕见的肿瘤实体,它模仿类似唾液腺的尖细胞分化。这种独特的亚型以低度恶性为特征,仅在少数病例中有记录。尽管经常被归类为 TNBC,但乳腺 PACC 的预后通常相对较好。我们的研究旨在通过全面回顾本院收治的病例,分析这些病例的临床、组织病理学和治疗情况(包括化疗和放疗)以及患者的预后,丰富目前对 PACC 的认识,并使我们能够汇编一个全面的数据集,用于深入分析治疗反应和长期生存率,从而有助于更广泛地了解该疾病的自然史。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer treatment reviews
Cancer treatment reviews 医学-肿瘤学
CiteScore
21.40
自引率
0.80%
发文量
109
审稿时长
13 days
期刊介绍: Cancer Treatment Reviews Journal Overview: International journal focused on developments in cancer treatment research Publishes state-of-the-art, authoritative reviews to keep clinicians and researchers informed Regular Sections in Each Issue: Comments on Controversy Tumor Reviews Anti-tumor Treatments New Drugs Complications of Treatment General and Supportive Care Laboratory/Clinic Interface Submission and Editorial System: Online submission and editorial system for Cancer Treatment Reviews
期刊最新文献
Editorial Board Selecting systemic treatment for metastatic neuroendocrine tumors of the lung—current evidence and clinical implications Incomplete ovarian function suppression in premenopausal breast cancer patients treated with gonadotropin-releasing hormone agonists CAR-T cell therapy for breast cancer: Current status and future perspective Dynamics of resistance to immunotherapy and TKI in patients with advanced renal cell carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1